<DOC>
	<DOCNO>NCT01827553</DOCNO>
	<brief_summary>This randomized trial examines effectiveness chemoradiotherapy compare chemotherapy alone induction chemotherapy 3 cycle gemcitabine 6 cycle FOLFIRINOX patient locally advance , non resectable non-metastatic pancreatic cancer . Chemotherapeutic agent chemoradiotherapy gemcitabine administer 5 cycle , agent administration sole chemotherapy determine induction chemotherapy . Operability tumor evaluate week 11 randomisation . Patients follow duration therapy 5 year last study treatment . Overall survival end follow define primary endpoint . Secondary endpoint tumor-free survival , rate local recurrence local progression , rate distant metastasis , acute late toxicity chemoradiotherapy , quality life , rate remission , rate curative resection ( R0 ) chemotherapy chemoradiotherapy . It plan include total number 830 patient .</brief_summary>
	<brief_title>Pancreatic Carcinoma : Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Age &gt; 18 year histologically confirm adenocarcinoma pancreas evidence distant metastasis base compute tomography thorax abdomen non resectable pancreatic cancer evidence peritoneal carcinosis ECOGperformance status ≤ 2 sign studyspecific consent form prior therapy fertile patient refuse effective contraception study treatment synchron second malignant neoplasm except basal cell carcinoma skin carcinoma situ cervix curative therapy Inclusion patient prior concurrent malignancy ( ≤ 5 year prior enrolment study ) must discuss chronic inflammatory disease intestine know allergic reaction study medication ontreatment participation trial insufficient liver function : Bilirubin &gt; 2,0 mg/dl ; SGOT , SGPT , alkaline phosphatase , gGT 3 time upper limit normal ( Stent implantation case obstructive jaundice ) ; cirrhosis liver Child B C insufficient bone marrow function : WBC &lt; 3,0 x 10^9/l , Platelets &gt; 100 x 10^9/l serum creatinine &gt; 1,5 mg/dl , creatinin clearance &lt; 60ml/min ( comparable test ) preexisting uncontrolled cardiac disease , sign cardiac failure , rhythm disturbance require therapy , myocardial infarction within past 6 month , unstable angina pectoris , congestive heart failure , New York Heart Association ( NYHA ) class III IV heart disease neurological and/or psychiatric disease : stroke , dementia , epilepsy , psychosis active intractable uncontrollable infection , HIVinfection prior radiotherapy chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>chemoradiotherapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>FOLFIRINOX</keyword>
	<keyword>gemcitabine</keyword>
</DOC>